TrialWire™ Platform was engaged by the sponsor at the recommendation of a US CRO.

This was a national DCT using one centralized site and Fedex for medication delivery and home visits for checkups.

The previous recruitment firm and methods were not able to manage the challenge of securing referrals within a specific time period from the onset of symptoms and diagnosis.

All patent engagement activity was via the Platform so patients could be quickly online screened and connected to the site for follow-up.

The study was fully recruited.